Marker Therapeutics, Inc.MRKRNASDAQ

Revenue (LTM)

$3.5T

+53810034.3% YoY

Net Income (LTM)

$-12.2T

-113346866.3% YoY

Free Cash Flow

$-12.0T

Revenue CAGR (5Y)

+2277.6%

Marginsimproving

FCF($12014.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	1	4↑183.0%	3↓5.8%	7↑99.1%	3,546,669↑53810034.3%
Gross Profit	-2	-8↓340.1%	-7↑16.0%	-7↑3.2%	0
Operating Income	-39	-20↑49.9%	-15↑26.3%	-11↑23.7%	-12,890,426↓115937970.8%
Net Income	-42	-30↑28.5%	-8↑72.5%	-11↓30.3%	-12,163,620↓113346866.3%
EBITDA	-39	-17↑56.1%	-12↑30.6%	-11↑5.7%	-12,890,426↓115937991.6%
EPS Diluted	-5.47	-3.58↑34.6%	-1.93↑46.1%	-1.19↑38.3%	-0.79↑33.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	42	12↓72.2%	15↑28.3%	19↑27.0%	16,068,048↑83720615.0%
Total Current Assets	46	17↓63.9%	17↑3.1%	22↑28.6%	19,070,997↑86596268.5%
Total Assets	68	34↓49.5%	17↓50.2%	22↑28.6%	19,070,997↑86596268.5%
Total Current Liabilities	13	8↓39.7%	3↓60.5%	3↑12.7%	2,274,183↑65643230.8%
Total Liabilities	24	15↓38.6%	3↓79.3%	3↑12.7%	2,274,183↑65643230.8%
Total Equity	44	20↓55.4%	14↓28.3%	19↑32.1%	16,796,814↑90507748.6%
Total Debt	12	8↓35.8%	0	0	0
Net Debt	-30	-4↑86.3%	-15↓262.8%	-19↓27.0%	-16,068,048↓83720615.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-27	-27↑1.1%	-16↑39.0%	-11↑33.6%	-12,014,081↓110116529.0%
Capital Expenditure	-3	0↑100.0%	0	0	0
Free Cash Flow	-30	-27↑11.3%	-16↑39.0%	-11↑33.6%	-12,014,081↓110116529.0%
Stock-Based Comp	6	0	1	0↓71.4%	537,540↑218632965.4%
Net Change in Cash	22	-32↓243.2%	3↑110.5%	4↑22.6%	-2,149,593↓52673421.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance